Piper Sandler launched the coverage of a raft of cancer-focused biotechs with bullish views on Monday while issuing a Neutral recommendation on Summit Therapeutics (NASDAQ:SMMT), citing an unfavorable ...

With the NBA's new schedule out, and training camps just weeks away, it's time to look ahead to the 2025-26 season. What does ...

Nvidia ( NVDA) may be the market's biggest AI stock, but institutional investors are still shying away. "NVDA is now the most ...

Jim Cramer, the popular host of the CNBC shows "Mad Money" and "Squawk on the Street," is well-known for dropping his hot ...

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $12.65, with a ...

XRP price predictions remain bullish, but altcoin investors are already pitching their tents with Unilabs (UNIL) as its ...

Bullish said it has received all $1.15 billion in capital raised from its IPO in stablecoins, marking a first for U.S. public ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

For its part, Macquarie raised its price target to $8 from $6 previously, marking a 32 percent upside potential from its ...

Solana price holds $180 support after double bottom rally from $160. Traders eye a return to $200 if buying strength ...